世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

オンコロジー臨床試験の世界市場に関する洞察、2028年までの予測


Global Oncology Clinical Trial Market Insights, Forecast to 2028

臨床試験は、研究室での研究から始まる長いプロセスの最終段階です。 市場の分析と洞察オンコロジー臨床試験の世界市場 オンコロジー臨床試験の世界市場規模は、2021年の1億3660万米ドルから2028年には1億6840... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年3月4日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

臨床試験は、研究室での研究から始まる長いプロセスの最終段階です。
市場の分析と洞察オンコロジー臨床試験の世界市場
オンコロジー臨床試験の世界市場規模は、2021年の1億3660万米ドルから2028年には1億6840万米ドルに達すると予測され、2022年から2028年の間に年平均成長率3.0%で推移するものと思われます。
オンコロジー臨床試験は、主にサロゲートエンドポイントを評価する初期段階の試験で、小規模、シングルアーム、オープンラベルであることが特徴です。

本レポートは、業界標準の分析精度と高いデータ整合性により、世界の腫瘍臨床試験市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得するために役立つ素晴らしい試みを行っています。本レポートの購入者は、世界の腫瘍学的臨床試験市場の全体規模(収益ベース)を含む、検証済みで信頼できる市場予測にアクセスすることができます。
全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の腫瘍学的臨床試験市場における持続的な成功を確実にするために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。本レポートを執筆したアナリストは、世界の腫瘍学臨床試験市場を詳細に調査するため、独自の業界最高水準の調査・分析アプローチを採用しています。

世界のオンコロジー臨床試験の範囲と市場規模
オンコロジー臨床試験市場は、プレイヤー別、地域(国)別、タイプ別、用途別に分類されます。世界の腫瘍学的臨床試験市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになります。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てます。

タイプ別セグメント
前立腺癌
肺がん
乳がん
白血病
その他
用途別セグメント
病院
クリニック
研究室

会社別
IQVIA
チャールズリバー研究所
アイコン・プラットフォーム
メデリス社
メドスペース・ホールディングス
パレクセル・インターナショナル
ファーマシューティカル・プロダクト・デベロプメント LLC
ピボタル
PRAヘルスサイエンス
サイネオス・ヘルス

地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他の欧州地域
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
ラテンアメリカ
メキシコ
ブラジル
ラテンアメリカの残りの地域
中近東・アフリカ
トルコ
サウジアラビア
UAE
MEAの残りの地域


ページTOPに戻る


目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Clinical Trial Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prostate Cancer
1.2.3 Lung Cancer
1.2.4 Breast Cancer
1.2.5 Leukemia
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Clinical Trial Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Lab
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncology Clinical Trial Market Perspective (2017-2028)
2.2 Oncology Clinical Trial Growth Trends by Region
2.2.1 Oncology Clinical Trial Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oncology Clinical Trial Historic Market Size by Region (2017-2022)
2.2.3 Oncology Clinical Trial Forecasted Market Size by Region (2023-2028)
2.3 Oncology Clinical Trial Market Dynamics
2.3.1 Oncology Clinical Trial Industry Trends
2.3.2 Oncology Clinical Trial Market Drivers
2.3.3 Oncology Clinical Trial Market Challenges
2.3.4 Oncology Clinical Trial Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Clinical Trial Players by Revenue
3.1.1 Global Top Oncology Clinical Trial Players by Revenue (2017-2022)
3.1.2 Global Oncology Clinical Trial Revenue Market Share by Players (2017-2022)
3.2 Global Oncology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Clinical Trial Revenue
3.4 Global Oncology Clinical Trial Market Concentration Ratio
3.4.1 Global Oncology Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Clinical Trial Revenue in 2021
3.5 Oncology Clinical Trial Key Players Head office and Area Served
3.6 Key Players Oncology Clinical Trial Product Solution and Service
3.7 Date of Enter into Oncology Clinical Trial Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Clinical Trial Breakdown Data by Type
4.1 Global Oncology Clinical Trial Historic Market Size by Type (2017-2022)
4.2 Global Oncology Clinical Trial Forecasted Market Size by Type (2023-2028)
5 Oncology Clinical Trial Breakdown Data by Application
5.1 Global Oncology Clinical Trial Historic Market Size by Application (2017-2022)
5.2 Global Oncology Clinical Trial Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oncology Clinical Trial Market Size (2017-2028)
6.2 North America Oncology Clinical Trial Market Size by Type
6.2.1 North America Oncology Clinical Trial Market Size by Type (2017-2022)
6.2.2 North America Oncology Clinical Trial Market Size by Type (2023-2028)
6.2.3 North America Oncology Clinical Trial Market Share by Type (2017-2028)
6.3 North America Oncology Clinical Trial Market Size by Application
6.3.1 North America Oncology Clinical Trial Market Size by Application (2017-2022)
6.3.2 North America Oncology Clinical Trial Market Size by Application (2023-2028)
6.3.3 North America Oncology Clinical Trial Market Share by Application (2017-2028)
6.4 North America Oncology Clinical Trial Market Size by Country
6.4.1 North America Oncology Clinical Trial Market Size by Country (2017-2022)
6.4.2 North America Oncology Clinical Trial Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Oncology Clinical Trial Market Size (2017-2028)
7.2 Europe Oncology Clinical Trial Market Size by Type
7.2.1 Europe Oncology Clinical Trial Market Size by Type (2017-2022)
7.2.2 Europe Oncology Clinical Trial Market Size by Type (2023-2028)
7.2.3 Europe Oncology Clinical Trial Market Share by Type (2017-2028)
7.3 Europe Oncology Clinical Trial Market Size by Application
7.3.1 Europe Oncology Clinical Trial Market Size by Application (2017-2022)
7.3.2 Europe Oncology Clinical Trial Market Size by Application (2023-2028)
7.3.3 Europe Oncology Clinical Trial Market Share by Application (2017-2028)
7.4 Europe Oncology Clinical Trial Market Size by Country
7.4.1 Europe Oncology Clinical Trial Market Size by Country (2017-2022)
7.4.2 Europe Oncology Clinical Trial Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Clinical Trial Market Size (2017-2028)
8.2 Asia-Pacific Oncology Clinical Trial Market Size by Type
8.2.1 Asia-Pacific Oncology Clinical Trial Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Oncology Clinical Trial Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Oncology Clinical Trial Market Share by Type (2017-2028)
8.3 Asia-Pacific Oncology Clinical Trial Market Size by Application
8.3.1 Asia-Pacific Oncology Clinical Trial Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Oncology Clinical Trial Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Oncology Clinical Trial Market Share by Application (2017-2028)
8.4 Asia-Pacific Oncology Clinical Trial Market Size by Region
8.4.1 Asia-Pacific Oncology Clinical Trial Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Oncology Clinical Trial Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oncology Clinical Trial Market Size (2017-2028)
9.2 Latin America Oncology Clinical Trial Market Size by Type
9.2.1 Latin America Oncology Clinical Trial Market Size by Type (2017-2022)
9.2.2 Latin America Oncology Clinical Trial Market Size by Type (2023-2028)
9.2.3 Latin America Oncology Clinical Trial Market Share by Type (2017-2028)
9.3 Latin America Oncology Clinical Trial Market Size by Application
9.3.1 Latin America Oncology Clinical Trial Market Size by Application (2017-2022)
9.3.2 Latin America Oncology Clinical Trial Market Size by Application (2023-2028)
9.3.3 Latin America Oncology Clinical Trial Market Share by Application (2017-2028)
9.4 Latin America Oncology Clinical Trial Market Size by Country
9.4.1 Latin America Oncology Clinical Trial Market Size by Country (2017-2022)
9.4.2 Latin America Oncology Clinical Trial Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Clinical Trial Market Size (2017-2028)
10.2 Middle East & Africa Oncology Clinical Trial Market Size by Type
10.2.1 Middle East & Africa Oncology Clinical Trial Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Oncology Clinical Trial Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Oncology Clinical Trial Market Share by Type (2017-2028)
10.3 Middle East & Africa Oncology Clinical Trial Market Size by Application
10.3.1 Middle East & Africa Oncology Clinical Trial Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Oncology Clinical Trial Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Oncology Clinical Trial Market Share by Application (2017-2028)
10.4 Middle East & Africa Oncology Clinical Trial Market Size by Country
10.4.1 Middle East & Africa Oncology Clinical Trial Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Oncology Clinical Trial Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Oncology Clinical Trial Introduction
11.1.4 IQVIA Revenue in Oncology Clinical Trial Business (2017-2022)
11.1.5 IQVIA Recent Developments
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Details
11.2.2 Charles River Laboratory Business Overview
11.2.3 Charles River Laboratory Oncology Clinical Trial Introduction
11.2.4 Charles River Laboratory Revenue in Oncology Clinical Trial Business (2017-2022)
11.2.5 Charles River Laboratory Recent Developments
11.3 ICON Plc
11.3.1 ICON Plc Company Details
11.3.2 ICON Plc Business Overview
11.3.3 ICON Plc Oncology Clinical Trial Introduction
11.3.4 ICON Plc Revenue in Oncology Clinical Trial Business (2017-2022)
11.3.5 ICON Plc Recent Developments
11.4 Medelis, Inc.
11.4.1 Medelis, Inc. Company Details
11.4.2 Medelis, Inc. Business Overview
11.4.3 Medelis, Inc. Oncology Clinical Trial Introduction
11.4.4 Medelis, Inc. Revenue in Oncology Clinical Trial Business (2017-2022)
11.4.5 Medelis, Inc. Recent Developments
11.5 Medpace Holdings, Inc.
11.5.1 Medpace Holdings, Inc. Company Details
11.5.2 Medpace Holdings, Inc. Business Overview
11.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Introduction
11.5.4 Medpace Holdings, Inc. Revenue in Oncology Clinical Trial Business (2017-2022)
11.5.5 Medpace Holdings, Inc. Recent Developments
11.6 PAREXEL International
11.6.1 PAREXEL International Company Details
11.6.2 PAREXEL International Business Overview
11.6.3 PAREXEL International Oncology Clinical Trial Introduction
11.6.4 PAREXEL International Revenue in Oncology Clinical Trial Business (2017-2022)
11.6.5 PAREXEL International Recent Developments
11.7 Pharmaceutical Product Development, LLC
11.7.1 Pharmaceutical Product Development, LLC Company Details
11.7.2 Pharmaceutical Product Development, LLC Business Overview
11.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Introduction
11.7.4 Pharmaceutical Product Development, LLC Revenue in Oncology Clinical Trial Business (2017-2022)
11.7.5 Pharmaceutical Product Development, LLC Recent Developments
11.8 Pivotal
11.8.1 Pivotal Company Details
11.8.2 Pivotal Business Overview
11.8.3 Pivotal Oncology Clinical Trial Introduction
11.8.4 Pivotal Revenue in Oncology Clinical Trial Business (2017-2022)
11.8.5 Pivotal Recent Developments
11.9 PRA Health Sciences
11.9.1 PRA Health Sciences Company Details
11.9.2 PRA Health Sciences Business Overview
11.9.3 PRA Health Sciences Oncology Clinical Trial Introduction
11.9.4 PRA Health Sciences Revenue in Oncology Clinical Trial Business (2017-2022)
11.9.5 PRA Health Sciences Recent Developments
11.10 Syneos Health
11.10.1 Syneos Health Company Details
11.10.2 Syneos Health Business Overview
11.10.3 Syneos Health Oncology Clinical Trial Introduction
11.10.4 Syneos Health Revenue in Oncology Clinical Trial Business (2017-2022)
11.10.5 Syneos Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

 

ページTOPに戻る


 

Summary

Clinical trials are the final step in a long process that begins with research in a lab.
Market Analysis and Insights: Global Oncology Clinical Trial Market
The global Oncology Clinical Trial market size is projected to reach US$ 16840 million by 2028, from US$ 13660 million in 2021, at a CAGR of 3.0% during 2022-2028.
Oncology trials are predominantly early-phase studies that evaluate surrogate end points and are small, single arm, and open label.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Clinical Trial market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Clinical Trial market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Clinical Trial market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Clinical Trial market.

Global Oncology Clinical Trial Scope and Market Size
Oncology Clinical Trial market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Oncology Clinical Trial market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Prostate Cancer
Lung Cancer
Breast Cancer
Leukemia
Others
Segment by Application
Hospital
Clinic
Lab

By Company
IQVIA
Charles River Laboratory
ICON Plc
Medelis, Inc.
Medpace Holdings, Inc.
PAREXEL International
Pharmaceutical Product Development, LLC
Pivotal
PRA Health Sciences
Syneos Health

By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA



ページTOPに戻る


Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Clinical Trial Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prostate Cancer
1.2.3 Lung Cancer
1.2.4 Breast Cancer
1.2.5 Leukemia
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Clinical Trial Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Lab
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncology Clinical Trial Market Perspective (2017-2028)
2.2 Oncology Clinical Trial Growth Trends by Region
2.2.1 Oncology Clinical Trial Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oncology Clinical Trial Historic Market Size by Region (2017-2022)
2.2.3 Oncology Clinical Trial Forecasted Market Size by Region (2023-2028)
2.3 Oncology Clinical Trial Market Dynamics
2.3.1 Oncology Clinical Trial Industry Trends
2.3.2 Oncology Clinical Trial Market Drivers
2.3.3 Oncology Clinical Trial Market Challenges
2.3.4 Oncology Clinical Trial Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Clinical Trial Players by Revenue
3.1.1 Global Top Oncology Clinical Trial Players by Revenue (2017-2022)
3.1.2 Global Oncology Clinical Trial Revenue Market Share by Players (2017-2022)
3.2 Global Oncology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Clinical Trial Revenue
3.4 Global Oncology Clinical Trial Market Concentration Ratio
3.4.1 Global Oncology Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Clinical Trial Revenue in 2021
3.5 Oncology Clinical Trial Key Players Head office and Area Served
3.6 Key Players Oncology Clinical Trial Product Solution and Service
3.7 Date of Enter into Oncology Clinical Trial Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Clinical Trial Breakdown Data by Type
4.1 Global Oncology Clinical Trial Historic Market Size by Type (2017-2022)
4.2 Global Oncology Clinical Trial Forecasted Market Size by Type (2023-2028)
5 Oncology Clinical Trial Breakdown Data by Application
5.1 Global Oncology Clinical Trial Historic Market Size by Application (2017-2022)
5.2 Global Oncology Clinical Trial Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oncology Clinical Trial Market Size (2017-2028)
6.2 North America Oncology Clinical Trial Market Size by Type
6.2.1 North America Oncology Clinical Trial Market Size by Type (2017-2022)
6.2.2 North America Oncology Clinical Trial Market Size by Type (2023-2028)
6.2.3 North America Oncology Clinical Trial Market Share by Type (2017-2028)
6.3 North America Oncology Clinical Trial Market Size by Application
6.3.1 North America Oncology Clinical Trial Market Size by Application (2017-2022)
6.3.2 North America Oncology Clinical Trial Market Size by Application (2023-2028)
6.3.3 North America Oncology Clinical Trial Market Share by Application (2017-2028)
6.4 North America Oncology Clinical Trial Market Size by Country
6.4.1 North America Oncology Clinical Trial Market Size by Country (2017-2022)
6.4.2 North America Oncology Clinical Trial Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Oncology Clinical Trial Market Size (2017-2028)
7.2 Europe Oncology Clinical Trial Market Size by Type
7.2.1 Europe Oncology Clinical Trial Market Size by Type (2017-2022)
7.2.2 Europe Oncology Clinical Trial Market Size by Type (2023-2028)
7.2.3 Europe Oncology Clinical Trial Market Share by Type (2017-2028)
7.3 Europe Oncology Clinical Trial Market Size by Application
7.3.1 Europe Oncology Clinical Trial Market Size by Application (2017-2022)
7.3.2 Europe Oncology Clinical Trial Market Size by Application (2023-2028)
7.3.3 Europe Oncology Clinical Trial Market Share by Application (2017-2028)
7.4 Europe Oncology Clinical Trial Market Size by Country
7.4.1 Europe Oncology Clinical Trial Market Size by Country (2017-2022)
7.4.2 Europe Oncology Clinical Trial Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Clinical Trial Market Size (2017-2028)
8.2 Asia-Pacific Oncology Clinical Trial Market Size by Type
8.2.1 Asia-Pacific Oncology Clinical Trial Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Oncology Clinical Trial Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Oncology Clinical Trial Market Share by Type (2017-2028)
8.3 Asia-Pacific Oncology Clinical Trial Market Size by Application
8.3.1 Asia-Pacific Oncology Clinical Trial Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Oncology Clinical Trial Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Oncology Clinical Trial Market Share by Application (2017-2028)
8.4 Asia-Pacific Oncology Clinical Trial Market Size by Region
8.4.1 Asia-Pacific Oncology Clinical Trial Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Oncology Clinical Trial Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oncology Clinical Trial Market Size (2017-2028)
9.2 Latin America Oncology Clinical Trial Market Size by Type
9.2.1 Latin America Oncology Clinical Trial Market Size by Type (2017-2022)
9.2.2 Latin America Oncology Clinical Trial Market Size by Type (2023-2028)
9.2.3 Latin America Oncology Clinical Trial Market Share by Type (2017-2028)
9.3 Latin America Oncology Clinical Trial Market Size by Application
9.3.1 Latin America Oncology Clinical Trial Market Size by Application (2017-2022)
9.3.2 Latin America Oncology Clinical Trial Market Size by Application (2023-2028)
9.3.3 Latin America Oncology Clinical Trial Market Share by Application (2017-2028)
9.4 Latin America Oncology Clinical Trial Market Size by Country
9.4.1 Latin America Oncology Clinical Trial Market Size by Country (2017-2022)
9.4.2 Latin America Oncology Clinical Trial Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Clinical Trial Market Size (2017-2028)
10.2 Middle East & Africa Oncology Clinical Trial Market Size by Type
10.2.1 Middle East & Africa Oncology Clinical Trial Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Oncology Clinical Trial Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Oncology Clinical Trial Market Share by Type (2017-2028)
10.3 Middle East & Africa Oncology Clinical Trial Market Size by Application
10.3.1 Middle East & Africa Oncology Clinical Trial Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Oncology Clinical Trial Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Oncology Clinical Trial Market Share by Application (2017-2028)
10.4 Middle East & Africa Oncology Clinical Trial Market Size by Country
10.4.1 Middle East & Africa Oncology Clinical Trial Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Oncology Clinical Trial Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Oncology Clinical Trial Introduction
11.1.4 IQVIA Revenue in Oncology Clinical Trial Business (2017-2022)
11.1.5 IQVIA Recent Developments
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Details
11.2.2 Charles River Laboratory Business Overview
11.2.3 Charles River Laboratory Oncology Clinical Trial Introduction
11.2.4 Charles River Laboratory Revenue in Oncology Clinical Trial Business (2017-2022)
11.2.5 Charles River Laboratory Recent Developments
11.3 ICON Plc
11.3.1 ICON Plc Company Details
11.3.2 ICON Plc Business Overview
11.3.3 ICON Plc Oncology Clinical Trial Introduction
11.3.4 ICON Plc Revenue in Oncology Clinical Trial Business (2017-2022)
11.3.5 ICON Plc Recent Developments
11.4 Medelis, Inc.
11.4.1 Medelis, Inc. Company Details
11.4.2 Medelis, Inc. Business Overview
11.4.3 Medelis, Inc. Oncology Clinical Trial Introduction
11.4.4 Medelis, Inc. Revenue in Oncology Clinical Trial Business (2017-2022)
11.4.5 Medelis, Inc. Recent Developments
11.5 Medpace Holdings, Inc.
11.5.1 Medpace Holdings, Inc. Company Details
11.5.2 Medpace Holdings, Inc. Business Overview
11.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Introduction
11.5.4 Medpace Holdings, Inc. Revenue in Oncology Clinical Trial Business (2017-2022)
11.5.5 Medpace Holdings, Inc. Recent Developments
11.6 PAREXEL International
11.6.1 PAREXEL International Company Details
11.6.2 PAREXEL International Business Overview
11.6.3 PAREXEL International Oncology Clinical Trial Introduction
11.6.4 PAREXEL International Revenue in Oncology Clinical Trial Business (2017-2022)
11.6.5 PAREXEL International Recent Developments
11.7 Pharmaceutical Product Development, LLC
11.7.1 Pharmaceutical Product Development, LLC Company Details
11.7.2 Pharmaceutical Product Development, LLC Business Overview
11.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Introduction
11.7.4 Pharmaceutical Product Development, LLC Revenue in Oncology Clinical Trial Business (2017-2022)
11.7.5 Pharmaceutical Product Development, LLC Recent Developments
11.8 Pivotal
11.8.1 Pivotal Company Details
11.8.2 Pivotal Business Overview
11.8.3 Pivotal Oncology Clinical Trial Introduction
11.8.4 Pivotal Revenue in Oncology Clinical Trial Business (2017-2022)
11.8.5 Pivotal Recent Developments
11.9 PRA Health Sciences
11.9.1 PRA Health Sciences Company Details
11.9.2 PRA Health Sciences Business Overview
11.9.3 PRA Health Sciences Oncology Clinical Trial Introduction
11.9.4 PRA Health Sciences Revenue in Oncology Clinical Trial Business (2017-2022)
11.9.5 PRA Health Sciences Recent Developments
11.10 Syneos Health
11.10.1 Syneos Health Company Details
11.10.2 Syneos Health Business Overview
11.10.3 Syneos Health Oncology Clinical Trial Introduction
11.10.4 Syneos Health Revenue in Oncology Clinical Trial Business (2017-2022)
11.10.5 Syneos Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(薬学的薬物)の最新刊レポート

本レポートと同じKEY WORD(clinical trial)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る